Viking Therapeutics Cash from Financing (TTM) Analysis

Viking Therapeutics Inc (VKTX)

74.31 +5.45 (+7.91%) USD | NASDAQ | Apr 26, 16:00

74.69 +0.38 (+0.51%) After-Hours: 20:00

Cash from Financing (TTM) Chart

Historical Cash from Financing (TTM) Data

View and export this data back to 2014. Upgrade now.

Date	Value
March 31, 2024	873.23M
December 31, 2023	271.38M
September 30, 2023	281.94M
June 30, 2023	282.02M
March 31, 2023	13.35M
December 31, 2022	4.163M
September 30, 2022	-6.539M
June 30, 2022	-6.805M
March 31, 2022	-3.317M
December 31, 2021	6.88M
September 30, 2021	7.297M
June 30, 2021	7.59M
March 31, 2021	6.108M
December 31, 2020	0.95M
September 30, 2020	0.715M
June 30, 2020	0.751M
March 31, 2020	0.595M
December 31, 2019	0.887M
September 30, 2019	1.001M
June 30, 2019	168.41M

Date	Value
March 31, 2019	238.30M
December 31, 2018	300.28M
September 30, 2018	314.70M
June 30, 2018	148.32M
March 31, 2018	82.17M
December 31, 2017	22.40M
September 30, 2017	8.675M
June 30, 2017	7.673M
March 31, 2017	12.93M
December 31, 2016	10.35M
September 30, 2016	9.282M
June 30, 2016	8.469M
March 31, 2016	22.17M
December 31, 2015	22.21M
September 30, 2015	22.64M
June 30, 2015	23.86M
March 31, 2015	2.150M
December 31, 2014	2.168M
September 30, 2014	1.981M
June 30, 2014	1.468M

Cash From Financing Definition

Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.

Read full definition.

Cash from Financing (TTM) Range, Past 5 Years

-6.805M

Minimum

Jun 2022

873.23M

Maximum

Mar 2024

95.53M

Average

5.136M

Median

Cash from Financing (TTM) Benchmarks